연구동향 분석

CXCL-13 Regulates Resistance to 5-Fluorouracil in Colorectal Cancer

Guolin Zhang Xin Luo Wei Zhang Engeng Chen Jianbin Xu Fei Wang Gaoyang Cao Zhenyu Ju Dongai Jin Xuefeng Huang Wei Zhou Zhangfa Song 2020년

논문상세정보
인용/피인용

' CXCL-13 Regulates Resistance to 5-Fluorouracil in Colorectal Cancer' 의 참고문헌

  • Worldwide variations in colorectal cancer
    Center MM [2009]
  • The expression of CXCL13 and its relation to unfavorable clinical characteristics in young breast cancer
    Chen L [2015]
  • Targeting CXCL13 during neuroinflammation
    Huber AK [2015]
  • Spatiotemporal dynamics of intratumoral immune cells reveal the immune landscape in human cancer
    Bindea, G. [2013]
  • Role of integrated cancer nanomedicine in overcoming drug resistance
    Iyer AK [2013]
  • Pharmacogenetics research on chemotherapy resistance in colorectal cancer over the last 20 years
    Panczyk M [2014]
  • Multi-drug resistance in cancer chemotherapeutics : mechanisms and lab approaches
    Wu Q [2014]
  • Molecular pathways : receptor ectodomain shedding in treatment, resistance, and monitoring of cancer
    Miller MA [2017]
  • MicroRNAs as regulators, biomarkers and therapeutic targets in the drug resistance of colorectal cancer
    Xie T [2016]
  • Mechanisms and insights into drug resistance in cancer
  • Irinotecan plus fluorouracil and leucovorin for metastatic colorectal cancer. Irinotecan Study Group
    Saltz LB [2000]
  • Global cancer statistics 2018 : GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries
    Bray F [2018]
  • Expression features of CXCR5 and its ligand, CXCL13 associated with poor prognosis of advanced colorectal cancer
    Qi XW [2014]
  • Epigenomics alternations and dynamic transcriptional changes in responses to 5-fluorouracil stimulation reveal mechanisms of acquired drug resistance of colorectal cancer cells
    Shen Y [2018]
  • EMT, cancer stem cells and drug resistance : an emerging axis of evil in the war on cancer
    Singh A [2010]
  • Different mechanisms of acquired resistance to fluorinated pyrimidines in human colorectal cancer cells
    Murakami Y [2000]
  • Cytokines in cancer drug resistance : cues to new therapeutic strategies
    Jones VS [2016]
  • ColoGuideEx : a robust gene classifier specific for stage II colorectal cancer prognosis
    Agesen TH [2012]
  • Circulating inflammatory factors associated with worse longterm prognosis in colorectal cancer
    Olsen RS [2017]
  • Chemokines in cancer
    Chow MT [2014]
  • Chemokines and chemokine receptors : new insights into cancer-related inflammation
    Lazennec G [2010]
  • Cancer and the chemokine network
    Balkwill F [2004]
  • CXCL13-producing TFH cells link immune suppression and adaptive memory in human breast cancer
  • CXCL13-CXCR5axis promotes the growth and invasion of colon cancer cells via PI3K/AKT pathway
    Zhu Z [2015]
  • CXCL13 is androgen-responsive and involved in androgen induced prostate cancer cell migration and invasion
    Fan L [2017]
  • CXCL13 inhibition prevents bone metastasis in hormone-refractory prostate cancer (133.8)
    Lillard J [2010]
  • CD4(+)follicular helper T cell infiltration predicts breast cancer survival
  • Autocrine mechanisms of cancer chemoresistance
    Butera G [2018]
  • Autocrine activation of JAK2 by IL-11 promotes platinum drug resistance
    Zhou W [2018]
  • 779 CXCL13-CXCR5 signaling is required for the anti-tumor immune response in colorectal cancer
    Waldner MJ [2014]